The DOI matches its Crossref record.
Role of TNF-α in Pulmonary Host Defense in Murine Invasive Aspergillosis
Abstract
Invasive pulmonary aspergillosis is a common and devastating complication of immunosuppression, whose incidence has increased dramatically in tandem with the increase in the number of immunocompromised patients. Given the role of TNF-α in other pulmonary infections, we hypothesized that TNF-α is an important proximal signal in murine invasive pulmonary aspergillosis. Intratracheal challenge with Aspergillus fumigatus conidia in both neutropenic (cyclophosphamide-treated) and nonneutropenic BALB/c mice resulted in the time-dependent increase in lung TNF-α levels, which correlated with the histologic development of a patchy, peribronchial infiltration of mononuclear and polymorphonuclear cells. Ab-mediated neutralization of TNF-α resulted in an increase in mortality in both normal and cyclophosphamide-treated animals, which was associated with increased lung fungal burden as determined by histology and as quantified by chitin content. Depletion of TNF-α resulted in a reduced lung neutrophil influx in both normal and cyclophosphamide-treated animals, which occurred in association with a decrease in lung levels of the C-X-C chemokine, macrophage inflammatory protein-2 and the C-C chemokines macrophage inflammatory protein-1α and JE. In cyclophosphamide-treated animals, intratracheal administration of a TNF-α agonist peptide (TNF70–80) 3 days before, but not concomitant with, the administration of Aspergillus conidia resulted in improved survival from 9% in control mice to 55% in TNF70–80-treated animals. These studies indicate that TNF-α is a critical component of innate immunity in both immunocompromised and immunocompetent hosts, and that pretreatment with a TNF-α agonist peptide in a compartmentalized fashion can significantly enhance resistance to A. fumigatus in neutropenic animals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Dectin-1 Mediates the Biological Effects of β-Glucans
Brown, G. D., Herre, J., Williams, D. L., Willment, J. A., Marshall, A. S. J., & Gordon, S. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021890 · Cited by 1,205
Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis
Dagenais, T. R. T., & Keller, N. P. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00055-08 · Cited by 993
Aspergillus Infections in Transplant Recipients
Singh, N., & Paterson, D. L. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.1.44-69.2005 · Cited by 579
The pathobiology of Aspergillus fumigatus
Latgé, J.-P. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(01)02104-7 · Cited by 546
Aspergillus fumigatus Triggers Inflammatory Responses by Stage-Specific β-Glucan Display
Hohl, T. M., Van Epps, H. L., Rivera, A., Morgan, L. A., Chen, P. L., Feldmesser, M., & Pamer, E. G. (2005) · PLoS Pathogens · doi:10.1371/journal.ppat.0010030 · Cited by 428
Requisite Role for the Dectin-1 β-Glucan Receptor in Pulmonary Defense against Aspergillus fumigatus
Werner, J. L., Metz, A. E., Horn, D., Schoeb, T. R., Hewitt, M. M., Schwiebert, L. M., Faro-Trindade, I., Brown, G. D., & Steele, C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804250 · Cited by 412
The immune response to fungal infections
Shoham, S., & Levitz, S. M. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05397.x · Cited by 392
Gersuk, G. M., Underhill, D. M., Zhu, L., & Marr, K. A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.6.3717 · Cited by 334
Fungal Infections Complicating Tumor Necrosis Factor α Blockade Therapy
Tsiodras, S., Samonis, G., Boumpas, D. T., & Kontoyiannis, D. P. (2008) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)60839-2 · Cited by 331
Invasive Pulmonary Aspergillosis Associated with Infliximab Therapy
(2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441415 · Cited by 330
Toll-like Receptor (TLR) Signaling in Response toAspergillus fumigatus
Mambula, S. S., Sau, K., Henneke, P., Golenbock, D. T., & Levitz, S. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201683200 · Cited by 298
Infections and anti–tumor necrosis factor α therapy
Ellerin, T., Rubin, R. H., & Weinblatt, M. E. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11301 · Cited by 284
Hebart, H., Bollinger, C., Fisch, P., Sarfati, J., Meisner, C., Baur, M., Loeffler, J., Monod, M., Latgé, J.-P., & Einsele, H. (2002) · Blood · doi:10.1182/blood-2002-01-0265 · Cited by 257
Aspergillus fumigatus : Principles of Pathogenesis and Host Defense
Hohl, T. M., & Feldmesser, M. (2007) · Eukaryotic Cell · doi:10.1128/ec.00274-07 · Cited by 237
Morrison, B. E., Park, S. J., Mooney, J. M., & Mehrad, B. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18125 · Cited by 234
Self-citationBalloy, V., Huerre, M., Latgé, J.-P., & Chignard, M. (2005) · Infection and Immunity · doi:10.1128/iai.73.1.494-503.2005 · Cited by 231
T Cell Vaccination in Mice with Invasive Pulmonary Aspergillosis
Cenci, E., Mencacci, A., Bacci, A., Bistoni, F., Kurup, V. P., & Romani, L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.1.381 · Cited by 223
Stephens-Romero, S. D., Mednick, A. J., & Feldmesser, M. (2005) · Infection and Immunity · doi:10.1128/iai.73.1.114-125.2005 · Cited by 131
Bouzani, M., Ok, M., McCormick, A., Ebel, F., Kurzai, O., Morton, C. O., Einsele, H., & Loeffler, J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003593 · Cited by 127
Cytokine profiling of pulmonary aspergillosis
Sambatakou, H., Pravica, V., Hutchinson, I. V., & Denning, D. W. (2006) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2006.00616.x · Cited by 83
Sainz, J., Pérez, E., Hassan, L., Moratalla, A., Romero, A., Collado, M. D., & Jurado, M. (2007) · Human Immunology · doi:10.1016/j.humimm.2006.10.011 · Cited by 81
Shepardson, K. M., Jhingran, A., Caffrey, A., Obar, J. J., Suratt, B. T., Berwin, B. L., Hohl, T. M., & Cramer, R. A. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004378 · Cited by 79
Transient Lung-Specific Expression of the Chemokine KC Improves Outcome in Invasive Aspergillosis
Mehrad, B., Wiekowski, M., Morrison, B. E., Chen, S.-C., Coronel, E. C., Manfra, D. J., & Lira, S. A. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200204-367oc · Cited by 71
Self-citationSainz, J., Salas-Alvarado, I., López-Fernández, E., Olmedo, C., Comino, A., García, F., Blanco, A., Gómez-Lopera, S., Oyonarte, S., Bueno, P., et al. (2010) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201002300205 · Cited by 56
Desoubeaux, G., & Cray, C. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00841 · Cited by 55
Seifert, M., Nairz, M., Schroll, A., Schrettl, M., Haas, H., & Weiss, G. (2008) · Immunobiology · doi:10.1016/j.imbio.2008.07.010 · Cited by 51
Cornish, E. J., Hurtgen, B. J., McInnerney, K., Burritt, N. L., Taylor, R. M., Jarvis, J. N., Wang, S. Y., & Burritt, J. B. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6854 · Cited by 48
Lupiañez, C. B., Canet, L. M., Carvalho, A., Alcazar-Fuoli, L., Springer, J., Lackner, M., Segura-Catena, J., Comino, A., Olmedo, C., Ríos, R., et al. (2016) · Infection and Immunity · doi:10.1128/iai.01359-15 · Cited by 42
Immunomodulation as a Therapy for Aspergillus Infection: Current Status and Future Perspectives
Lauruschkat, C. D., Einsele, H., & Loeffler, J. (2018) · Journal of Fungi · doi:10.3390/jof4040137 · Cited by 32
Metadata
- Authors
- Mehrad, B., Strieter, R. M., & Standiford, T. J.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-02-01
- Volume
- 162
- Issue
- 3
- Pages
- 1633-1640
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W4313347792
- Cited by
- 240
- References
- 0
- FWCI
- 6.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.